Extracellular Matrix Research, Hepatic System, Non-Alcoholic Fatty Liver Disease
4. Jul 2019
Performance of the PRO-C3 collagen neo-epitope biomarker in non-alcoholic fatty liver disease.
There is an unmet need for non-invasive biomarkers in non-alcoholic fatty liver disease (NAFLD) that can diagnose advanced disease and identify patients suitable for clinical trials. The PRO-C3 collagen neo-epitope is a putative direct marker of fibrogenesis. We assessed the performance of PRO-C3 in…
Read the publication
Journal:
Authors:
- Boyle M,
- tiniakos D,
- Schattenberg JM,
- Ratziu V,
- Bugianessi E,
- Petta S,
- Oliveira CP,
- Govaere O,
- Yournes R,
- McPherson S,
- Bedossa P,
- Nielsen MJ,
- Karsdal M,
- Leeming D,
- Kendrick S,
- Anstee QM,